{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:46:01Z","timestamp":1792644361682,"version":"4.5.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>We investigated whether the vasopressin-analog, terlipressin induces systemic vasoconstriction and pulmonary vasodilation in a porcine model of acute pulmonary embolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Controlled, animal study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Tertiary medical center research laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects:<\/jats:title>\n                    <jats:p>\n                      Female pigs (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 12, Cross of Land Race, Duroc, and Yorkshire ~ 60 kg).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>\n                      Acute pulmonary embolism was induced by administration of three large autologous emboli. Animals then received four increasing doses of either terlipressin (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6) or vehicle (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 6).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Effects were evaluated in vivo at baseline, after pulmonary embolism and after each dose by invasive hemodynamic measures, transesophageal echocardiography, and blood analysis. Isolated pulmonary arteries were evaluated ex vivo in a myograph. Pulmonary embolism caused a four-fold increase in pulmonary vascular resistance (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) and a two-fold increase in mean pulmonary arterial pressure (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) compared with baseline. Terlipressin increased mean systemic blood pressure (28\u2009\u00b1\u20095\u2009mm Hg;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) and systemic vascular resistance (1,320\u2009\u00b1\u2009143 dynes;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) compared with vehicle. In the pulmonary circulation, terlipressin decreased mean pulmonary arterial pressure (\u20136.5\u2009\u00b1\u20091.8\u2009mm Hg;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.005) and tended to decrease pulmonary vascular resistance (\u201383\u2009\u00b1\u200933 dynes;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.07). Terlipressin decreased cardiac output (\u20132.5\u2009\u00b1\u20090.5\u2009L\/min;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001) and increased plasma lactate (2.7\u2009\u00b1\u20090.2 mmol\/L;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.0001), possibly indicating systemic hypoperfusion. A biomarker of cerebral ischemia, S100b, remained unchanged, suggesting preserved cerebral perfusion (0.17\u2009\u00b1\u20090.11 \u00b5g\/L;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.51). Ex vivo, terlipressin relaxed pulmonary and constricted mesenteric arteries.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Terlipressin caused systemic vasoconstriction and pulmonary vasodilation in a porcine in vivo model of acute pulmonary embolism and vasorelaxation in isolated pulmonary arteries. Despite positive vascular effects, cardiac output declined and plasma lactate increased probably due to a predominantly systemic vasoconstrictor effect of terlipressin. These findings should warrant careful translation to the clinical setting and does not suggest routine use in acute pulmonary embolism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004243","type":"journal-article","created":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T03:33:52Z","timestamp":1581910432000},"page":"e308-e315","source":"Crossref","is-referenced-by-count":17,"title":["Terlipressin Increases Systemic and Lowers Pulmonary Arterial Pressure in Experimental Acute Pulmonary Embolism"],"prefix":"10.1097","volume":"48","author":[{"given":"Jacob","family":"Schultz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads D.","family":"Lyhne","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D. R.","family":"Arcanjo","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Physiology, Federal University of Piau\u00ed, Teresina, Brazil."},{"name":"Institute of Biomedicine, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Kjaergaard","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic, Aalborg University Hospital, Aalborg, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Simonsen","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Erik","family":"Nielsen-Kudsk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark."},{"name":"Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc9264","article-title":"Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review.","volume":"14","author":"Price","year":"2010","journal-title":"Crit Care"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ejhf.478","article-title":"Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.","volume":"18","author":"Harjola","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) * * Endorsed by the European Respiratory Society (ERS).","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc7990","article-title":"Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study.","volume":"13","author":"Morelli","year":"2009","journal-title":"Crit Care"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.ph.42.030180.001253","article-title":"Humoral control of the pulmonary circulation.","volume":"42","author":"Bergofsky","year":"1980","journal-title":"Annu Rev Physiol"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/cc2338","article-title":"Science review: Vasopressin and the cardiovascular system part 2 - clinical physiology.","volume":"8","author":"Holmes","year":"2004","journal-title":"Crit Care"},{"key":"R7-20230728","first-page":"H1228","article-title":"Effects of vasopressin on pulmonary and systemic vascular mechanics.","volume":"257","author":"Wallace","year":"1989","journal-title":"Am J Physiol"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1378\/chest.103.4.1241","article-title":"Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide.","volume":"103","author":"Evora","year":"1993","journal-title":"Chest"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1097\/00003246-200211000-00024","article-title":"Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension.","volume":"30","author":"Leather","year":"2002","journal-title":"Crit Care Med"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/01.CCM.0000063042.15272.84","article-title":"Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.","volume":"31","author":"Westphal","year":"2003","journal-title":"Crit Care Med"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research.","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"2045893217738217","DOI":"10.1177\/2045893217738217","article-title":"A porcine in-vivo model of acute pulmonary embolism.","volume":"8","author":"Schultz","year":"2018","journal-title":"Pulm Circ"},{"key":"R13-20230728","first-page":"22","article-title":"Vasopressin vs terlipressin in treatment of refractory shock.","volume":"5","author":"Scarpati","year":"2013","journal-title":"Transl Med UniSa"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00134-007-0946-y","article-title":"Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.","volume":"34","author":"Lange","year":"2008","journal-title":"Intensive Care Med"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.","volume":"129","author":"Kucher","year":"2014","journal-title":"Circulation"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/cc2337","article-title":"Science review: Vasopressin and the cardiovascular system part 1\u2013receptor physiology.","volume":"7","author":"Holmes","year":"2003","journal-title":"Crit Care"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/endo-109-5-1778","article-title":"Effect of vasopressin blockade on blood pressure regulation during hemorrhage in conscious dogs.","volume":"109","author":"Schwartz","year":"1981","journal-title":"Endocrinology"},{"key":"R18-20230728","first-page":"106","article-title":"Role of vasopressin in cardiovascular and blood pressure regulation.","volume":"27","author":"Abboud","year":"1990","journal-title":"Blood Vessels"},{"key":"R19-20230728","first-page":"H743","article-title":"Role of nitric oxide in vasopressinergic pulmonary vasodilatation.","volume":"262","author":"Russ","year":"1992","journal-title":"Am J Physiol"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"H832","DOI":"10.1152\/ajpheart.00249.2011","article-title":"Biochemical and myofilament responses of the right ventricle to severe pulmonary hypertension.","volume":"301","author":"Walker","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R21-20230728","first-page":"H1009","article-title":"Pulmonary vasoactive effects of exogenous and endogenous AVP in conscious dogs.","volume":"251","author":"Nyhan","year":"1986","journal-title":"Am J Physiol"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(95)00343-J","article-title":"Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin.","volume":"282","author":"Sai","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/pr.2013.221","article-title":"Age dependency of vasopressin pulmonary vasodilatory effect in rats.","volume":"75","author":"Enomoto","year":"2014","journal-title":"Pediatr Res"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ejcts.2006.02.032","article-title":"Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.","volume":"29","author":"Jeon","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0003319711411704","article-title":"Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: An echo study.","volume":"63","author":"Kalambokis","year":"2012","journal-title":"Angiology"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3748\/wjg.v10.i15.2278","article-title":"Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: An echocardiographic assessment.","volume":"10","author":"Altintas","year":"2004","journal-title":"World J Gastroenterol"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1510\/icvts.2007.159624","article-title":"Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension.","volume":"6","author":"Tayama","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jtcvs.2004.06.043","article-title":"Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return.","volume":"129","author":"Scheurer","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1017\/S1047951105000193","article-title":"The role of vasopressin in treating systemic inflammatory syndrome complicated by right ventricular failure.","volume":"15","author":"Vida","year":"2005","journal-title":"Cardiol Young"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","article-title":"Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial.","volume":"32","author":"Lauzier","year":"2006","journal-title":"Intensive Care Med"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.resuscitation.2006.07.030","article-title":"Arginine vasopressin during sinus rhythm: Effects on haemodynamic variables, left anterior descending coronary artery cross sectional area and cardiac index, before and after inhibition of NO-synthase, in pigs.","volume":"74","author":"Mayr","year":"2007","journal-title":"Resuscitation"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF00263525","article-title":"The physiological effects of vasopressin when used to control intra-abdominal bleeding.","volume":"14","author":"Shelly","year":"1988","journal-title":"Intensive Care Med"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(00)00853-0","article-title":"Effects of arginine vasopressin in the heart are mediated by specific intravascular endothelial receptors.","volume":"410","author":"Zenteno-Savin","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"R34-20230728","first-page":"H734","article-title":"Direct cardiac effects of vasopressin and their reversal by a vascular antagonist.","volume":"251","author":"Boyle","year":"1986","journal-title":"Am J Physiol"},{"key":"R35-20230728","first-page":"H53","article-title":"Effect of vasopressin on left ventricular performance.","volume":"264","author":"Cheng","year":"1993","journal-title":"Am J Physiol"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00134-002-1265-y","article-title":"Cardiac performance during vasopressin infusion in postcardiotomy shock.","volume":"28","author":"D\u00fcnser","year":"2002","journal-title":"Intensive Care Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.RES.24.6.787","article-title":"Mechanism of vasopressin-induced bradycardia in dogs.","volume":"24","author":"Varma","year":"1969","journal-title":"Circ Res"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00134-009-1630-1","article-title":"Comparing two different arginine vasopressin doses in advanced vasodilatory shock: A randomized, controlled, open-label trial.","volume":"36","author":"Torgersen","year":"2010","journal-title":"Intensive Care Med"},{"key":"R39-20230728","first-page":"H261","article-title":"Direct cardiac effects of vasopressin: Role of V1- and V2-vasopressinergic receptors.","volume":"255","author":"Walker","year":"1988","journal-title":"Am J Physiol"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.03.001","article-title":"S100B protein in serum is elevated after global cerebral ischemic injury.","volume":"4","author":"Sun","year":"2013","journal-title":"World J Emerg Med"},{"key":"R41-20230728","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hep.510270206","article-title":"Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.","volume":"27","author":"Bernadich","year":"1998","journal-title":"Hepatology"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:38:57Z","timestamp":1690529937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004243","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}